Pa. Crifasi et al., DNA FLUORESCENT-PROBES FOR DIAGNOSIS OF VELOCARDIOFACIAL AND RELATED SYNDROMES, Mayo Clinic proceedings, 70(12), 1995, pp. 1148-1153
Objective: To study the usefulness of fluorescent in situ hybridizatio
n (FISH) with the DNA probe D22S75 for detecting microdeletions in chr
omosome 22q11.2 in metaphases from patients with features of ''CATCH 2
2'' (cardiac anomalies, abnormal facies, thymic hypoplasia or aplasia,
cleft palate, and hypocalcemia). Methods: High-resolution chromosome
analysis and FISH were performed on metaphases from 10 control subject
s, 42 patients with features of CATCH 22, and 6 parents of children wi
th CATCH 22, Patients were screened for conotruncal heart defect, pala
tal abnormality, and facial features, We correlated the phenotype, kar
yotype, and deletion of a D22S75 locus. Results: Specimens from nine p
atients with one or more features of CATCH 22 had a single hybridizati
on signal for D22S75, indicating a deletion of chromosome 22q11.2. Fou
r patients had ail the major features of the syndrome and a chromosoma
l deletion, Thirteen patients had two CATCH 22 features, five of whom
had a deletion, None of the 25 patients with a single CATCH 22 feature
had a deletion, One patient with a deletion detected by FISH also had
a deletion noted on high-resolution banding, All six parents who had
blood samples studied by FISH had normal hybridization patterns, Concl
usion: FISH is a useful adjunct to chromosome analysis for assessing p
atients with features of CATCH 22, Detecting a chromosomal deletion by
FISH provides a definitive diagnosis and helps to ensure appropriate
medical management and genetic counseling.